[HTML][HTML] Skin barrier and autoimmunity—mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin
… Combining conventional systemic corticosteroids with rituximab treatment has also … treatment
and emerging therapeutics for autoimmune skin blistering diseases and highlight blistering …
and emerging therapeutics for autoimmune skin blistering diseases and highlight blistering …
Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita-Brazilian …
CG Santi, AC Gripp, AM Roselino, DS Mello… - Anais brasileiros de …, 2019 - SciELO Brasil
… MMP from other diseases with mucocutaneous involvement. 53 Chan … Oral cavity trauma
using ill-fitting dentures can lead to the … of protein A immunoadsorption and rituximab: a protocol …
using ill-fitting dentures can lead to the … of protein A immunoadsorption and rituximab: a protocol …
Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real‐life data from a single centre
L Huseynova Terzi, N Akdogan… - … Journal of Clinical …, 2021 - Wiley Online Library
… The model fit was assessed using appropriate residual and goodness-of-… disease, affected
sites (mucosal only or mucosal and skin), duration of disease to the initiation of the treatment …
sites (mucosal only or mucosal and skin), duration of disease to the initiation of the treatment …
[PDF][PDF] Efficacy of Rituximab in the treatment of pemphigus: experience of Moroccan population
HB Bay, G Senhaji, S Elloudi… - Our Dermatology …, 2019 - pdfs.semanticscholar.org
… Our aim was to analyze the efficacy and tolerance of Rituximab in the … Where does
rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease? 2012;11:622-5. …
rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease? 2012;11:622-5. …
[HTML][HTML] Pemphigus: current and future therapeutic strategies
D Didona, R Maglie, R Eming, M Hertl - Frontiers in immunology, 2019 - frontiersin.org
… , as early rituximab use results in higher disease remission rates… group of autoimmune chronic
blistering skin diseases, which … dominant to a mucocutaneous phenotype with skin lesions …
blistering skin diseases, which … dominant to a mucocutaneous phenotype with skin lesions …
Oral lesions in autoimmune bullous diseases: an overview of clinical characteristics and diagnostic algorithm
H Rashid, A Lamberts, GFH Diercks, HH Pas… - American journal of …, 2019 - Springer
… Pemphigus diseases comprise mucocutaneous intra-epithelial blistering … These manifestations
are also seen in the genetic skin blistering disorder, dystrophic epidermolysis bullosa …
are also seen in the genetic skin blistering disorder, dystrophic epidermolysis bullosa …
Comprehensive review on the pathophysiology, clinical variants and management of pemphigus
… The diagnosis of bullous skin diseases is based on the typical skin … there is no cure for
autoimmune blistering diseases, they can … Rituximab is a chimeric type I anti-CD20 monoclonal …
autoimmune blistering diseases, they can … Rituximab is a chimeric type I anti-CD20 monoclonal …
Treatment of pemphigus vulgaris: part 2–emerging therapies
RL Yanovsky, M McLeod, AR Ahmed - Expert review of clinical …, 2019 - Taylor & Francis
… -Dsg3 and anti-Dsg1 will have both mucosal and skin involvement. Patients with … rituximab
therapy using a disease-specific protocol, for the treatment of autoimmune blistering diseases …
therapy using a disease-specific protocol, for the treatment of autoimmune blistering diseases …
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris
MKY Chen, R Vissapragada, N Bulamu… - JAMA …, 2022 - jamanetwork.com
… et al; French study group on autoimmune bullous skin diseases. First-line rituximab …
For the probabilistic sensitivity analyses, each input parameter was fitted into a distribution (…
For the probabilistic sensitivity analyses, each input parameter was fitted into a distribution (…
[HTML][HTML] Rituximab-progress but still not a final resolution for pemphigus patients: clinical report from a single center study
… diseases are a group of autoimmune bullous disorders … patients with the mucocutaneous
disease, which is contrary to … a one-size-fits-all approach in the management of pemphigus. …
disease, which is contrary to … a one-size-fits-all approach in the management of pemphigus. …